| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 147,322 | 142,291 | 124,302 | 108,648 | | Cost of Revenue | 127,781 | 141,987 | 130,124 | 111,618 | | | Gross Profit | 19,541 | 304 | (5,822) | (2,970) | | | Operating Expenses | | Research Development | 23,389 |
-
|
-
|
-
| | Selling General and Administrative | 14,354 | 10,475 | 9,349 | 11,582 | | Non Recurring | 1,766 | 6,196 | 4,933 | (12,895) | | Others | (1,547) | 457 | 1,090 |
-
| | | | Total Operating Expenses | 37,962 |
-
|
-
|
-
| | | | Operating Income or Loss | (2,273) | (16,824) | (21,194) | (1,657) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,279 | 1,114 | 1,456 | 836 | | Earnings Before Interest And Taxes | (2,142) | (15,710) | (20,171) | (388) | | Interest Expense | 66 | 545 | 442 | 421 | | Income Before Tax | (2,208) | (16,255) | (20,613) | (809) | | Income Tax Expense | (2,020) | (5,774) | (8,035) | (229) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (188) | (10,481) | (12,578) | (580) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 644 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (188) | (10,481) | (12,578) | 64 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($188) | ($10,481) | ($12,578) | $64 |
|
0.51% Nasdaq 
0.10 (0.67%) 
Income Statement
